Van Bennekom CM - Search Results

1

Vasoactive exposures during pregnancy and risk of microtia.

Van Bennekom CM, Mitchell AA, Moore CA, Werler MM; National Birth Defects Prevention Study. Van Bennekom CM, et al. Birth Defects Res A Clin Mol Teratol. 2013 Jan;97(1):53-9. doi: 10.1002/bdra.23101. Epub 2012 Nov 24. Birth Defects Res A Clin Mol Teratol. 2013. PMID: 23180593 Free PMC article.

2

Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.

Parker SE, Van Bennekom C, Anderka M, Mitchell AA; National Birth Defects Prevention Study. Parker SE, et al. Obstet Gynecol. 2018 Aug;132(2):385-394. doi: 10.1097/AOG.0000000000002679. Obstet Gynecol. 2018. PMID: 29995744

3

Oseltamivir exposure in pregnancy and the risk of specific birth defects.

Van Bennekom CM, Kerr SM, Mitchell AA. Van Bennekom CM, et al. Birth Defects Res. 2019 Nov 15;111(19):1479-1486. doi: 10.1002/bdr2.1563. Epub 2019 Aug 8. Birth Defects Res. 2019. PMID: 31397115

4

Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring.

Kerr SM, Van Bennekom CM, Mitchell AA. Kerr SM, et al. Among authors: van bennekom cm. Birth Defects Res. 2020 Mar;112(5):393-403. doi: 10.1002/bdr2.1642. Epub 2020 Jan 5. Birth Defects Res. 2020. PMID: 31903700

5

Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study.

Dukhovny S, Van Bennekom CM, Gagnon DR, Hernandez Diaz S, Parker SE, Anderka M, Werler MM, Mitchell AA. Dukhovny S, et al. Among authors: van bennekom cm. Birth Defects Res. 2018 Apr 17;110(7):579-586. doi: 10.1002/bdr2.1199. Epub 2018 Feb 1. Birth Defects Res. 2018. PMID: 29388358

6

Risk factors for congenital microcephaly in the pre-Zika era.

Kerr SM, Van Bennekom CM, Mitchell AA. Kerr SM, et al. Among authors: van bennekom cm. Birth Defects Res. 2019 Jan 15;111(2):96-118. doi: 10.1002/bdr2.1443. Epub 2018 Dec 24. Birth Defects Res. 2019. PMID: 30584689

7

Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.

van Gelder MM, Van Bennekom CM, Louik C, Werler MM, Roeleveld N, Mitchell AA. van Gelder MM, et al. Among authors: van bennekom cm. BJOG. 2015 Jun;122(7):1002-9. doi: 10.1111/1471-0528.13138. Epub 2014 Nov 14. BJOG. 2015. PMID: 25395267

8

Validity of maternal recall of gestational age and weight at birth: Comparison of structured interview and medical records.

Petersen JM, Mitchell AA, Van Bennekom C, Werler MM. Petersen JM, et al. Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):269-273. doi: 10.1002/pds.4699. Epub 2018 Nov 29. Pharmacoepidemiol Drug Saf. 2019. PMID: 30488571

9

Trends in first-trimester nausea and vomiting of pregnancy and use of select treatments: Findings from the National Birth Defects Prevention Study.

Schrager NL, Adrien N, Werler MM, Parker SE, Van Bennekom C, Mitchell AA; National Birth Defects Prevention Study. Schrager NL, et al. Paediatr Perinat Epidemiol. 2021 Jan;35(1):57-64. doi: 10.1111/ppe.12705. Epub 2020 Jul 4. Paediatr Perinat Epidemiol. 2021. PMID: 32623767 Free PMC article.

10

Comments on: are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.

Van Bennekom CM, Mitchell AA. Van Bennekom CM, et al. Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):439. doi: 10.1002/pds.3573. Pharmacoepidemiol Drug Saf. 2014. PMID: 24706419 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters